Identification of chemical entities from prescribed drugs for ovarian cancer by text mining of medical records

被引:0
作者
Tidke, Sonali Kothari [1 ]
Khedkar, Vijayshri [2 ]
Gupta, Anvita [2 ]
Goswami, Adhiraj Dev [2 ]
Agrawal, Muskaan [2 ]
Jaggi, Kajal [2 ]
机构
[1] Symbiosis Inst Technol, Dept Comp Sci & Engn, Pune, Maharashtra, India
[2] Symbiosis Inst Technol, Dept Informat Technol, Pune, Maharashtra, India
来源
2022 INTERNATIONAL CONFERENCE ON DECISION AID SCIENCES AND APPLICATIONS (DASA) | 2022年
关键词
Ovarian cancer; Text mining; Machine learning; Deep learning; Natural Language processing (NLP);
D O I
10.1109/DASA54658.2022.9765011
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
With the emerging technologies and latest trends in the information technology sector, machine learning can be said as one of the most powerful means in developing various software which are helping the business as well as the industries, the government, and private organizations, which shows the change in the emergence of this technology in the healthcare sector. Healthcare can be said to be the most important aspect of the 21st century. With the spread of various diseases and also the pandemic which had hit the world recently the healthcare system must come up with efficient drugs which are liable and are for a sure cure to the disease. Proposed research involves use of various machine learning tools and deep learning techniques. The algorithm uses text mining and NLP for extraction of chemical data from the related research papers and a drug dictionary is created. This dictionary contains specific targeted chemical data related to drugs used for treating ovarian cancer and will help in suggesting personalized drugs to patients. Our primary focus is ovarian cancer. Ovarian cancer is not only deadly to women but also very tough to get the correct diagnosis. It is considered the third most crucial cancer within Indian women.
引用
收藏
页码:475 / 479
页数:5
相关论文
共 15 条
  • [1] Atanassova Iana, 2019, Front Res Metr Anal, V4, P2, DOI 10.3389/frma.2019.00002
  • [2] Chukwuochaa Chukwuka, 8 INT C ADV COMPUTIN
  • [3] Kishor K. R. C., 2021, J PHYS C SERIES, V2089, P012048, DOI 10.1088/1742-6596/2089/1/012048
  • [4] Kothari Sonali, LIB PHILOS PRACTICE, P5590
  • [5] The growing role of precision and personalized medicine for cancer treatment
    Krzyszczyk, Paulina
    Acevedo, Alison
    Davidoff, Erika J.
    Timmins, Lauren M.
    Marrero-Berrios, Ileana
    Patel, Misaal
    White, Corina
    Lowe, Christopher
    Sherba, Joseph J.
    Hartmanshenn, Clara
    O'Neill, Kate M.
    Balter, Max L.
    Fritz, Zachary R.
    Androulakis, Ioannis P.
    Schloss, Rene S.
    Yarmush, Martin L.
    [J]. TECHNOLOGY, 2018, 6 (3-4): : 79 - 100
  • [6] Machine learning in chemoinformatics and drug discovery
    Lo, Yu-Chen
    Rensi, Stefano E.
    Torng, Wen
    Altman, Russ B.
    [J]. DRUG DISCOVERY TODAY, 2018, 23 (08) : 1538 - 1546
  • [7] The impact of chemoinformatics on drug discovery in the pharmaceutical industry
    Martinez-Mayorga, Karina
    Madariaga-Mazon, Abraham
    Medina-Franco, Jose L.
    Maggiora, Gerald
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2020, 15 (03) : 293 - 306
  • [8] Mohs Richard C, 2017, Alzheimers Dement (N Y), V3, P651, DOI 10.1016/j.trci.2017.10.005
  • [9] Popa Alina, 2020, P INT C APPL STAT, V2, P254, DOI [10.2478/icas-2021-0023, DOI 10.2478/ICAS-2021-0023]
  • [10] Salloum Said, 2018, STUDIES COMPUTATIONA, DOI [10.1007/978-3-319-67056-0_18, DOI 10.1007/978-3-319-67056-0_18]